The suggestion comes in the wake of tempers running high at testing centres with people demanding immediate results of their ELISA test which is performed to diagnose the disease.
"There is panic or hysteria that has been created in the community with high tempers where people are demanding dengue ELISA reports immediately quoting its availability and recommendation by authorities. The perception created in the minds of the public is that nothing can be done unless Dengue ELISA report is made available.
Wattal further said that contrary to the rapid tests the results of which are available in 15-30 mins, the ELISA IgM tests cannot be done on a single sample basis and takes a minimum of 4-6 hours.
"The ELISA IgM antigen tests cannot be done on a single sample basis unlike the rapid spot test and takes a minimum of 4-6 hours to give results. It requires optimal batching of samples to a certain number to ensure optimal utilisation of the assay and cannot be done in a hurry.
Noting there is no specific anti-viral therapy for dengue disease, the President of IAMM, Dr B L Sherwal said a patient need not wait for a laboratory confirmation to start the supportive treatment.
"Other laboratory parameters like Hbgm per cent, platelet count and PCV values need be taken into consideration as they can predict the severity of the disease irrespective of the dengue ELISA report. These laboratory results take much less time than an ELISA report," Dr Sherwal said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
